# Cogent Biosciences, Inc. (COGT): MoatMap facts

As of 14 Oct 2026. Research data, not investment advice.

As of 14 Oct 2026, MoatMap's StockRank for Cogent Biosciences, Inc. (COGT) is 10/100, ranked against 24,000+ stocks in 35 markets (Quality 25, Value 23, Momentum 36, each scored against its sector).

- StockRank: 10/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 25, Value 23, Momentum 36: each a 0-100 percentile within the stock's sector.
- Position: #24,277 overall, #2,303 in Healthcare.
- Listing: United States, NMS; Healthcare / Biotechnology.
- Last close: 29.78 USD on 12 Oct 2026.
- Insider filings, last 180 days: directors sold USD 1.7M.

Source: https://moatmap.ai/stock/COGT
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker